Nitrofurantoin BE study [Regulatives / Guidelines]

posted by pjs – India, 2015-08-27 17:36 (3217 d 23:18 ago) – Posting: # 15359
Views: 9,993

Dear all,

Apologies for the consecutive post.

❝ Please suggest statistical evaluation of tmax is required in this BE study or not.


Pls share your views for the mentioned.

How to decide what is clinically relevant and what is not?

What is the usual practice? to keep the Statistical evalution of Tmax or not?

What justification can be given if statistically significant diff is found between Tmax of test and ref but BE criteria is fulfilled in terms of Cmax nad AUC.

Regards,
PJS

Complete thread:

UA Flag
Activity
 Admin contact
23,057 posts in 4,840 threads, 1,641 registered users;
76 visitors (0 registered, 76 guests [including 4 identified bots]).
Forum time: 16:54 CEST (Europe/Vienna)

You should treat as many patients as possible with the new drugs
while they still have the power to heal.    Armand Trousseau

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5